INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of Oak Street Health, Inc. (OSH) Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Oak Street Health, Inc. (“Oak Street” or the “Company”) (NYSE: OSH). The investigation concerns whether Oak Street has violated the federal securities laws and/or engaged in other unlawful business practices.

Oak Street operates primary care centers serving Medicare beneficiaries. The Company contracts with health plans to generate medical costs savings and realize a return on its investment in primary care.

On November 8, 2021, Oak Street disclosed that the U.S. Department of Justice (“DOJ”) is investigating whether the Company may have violated the False Claims Act. Specifically, Oak Street disclosed in a Form 10-Q that on November 1, 2021, it received a civil investigative demand (“CID”) from the DOJ requesting documents and information related to the Company providing free transportation to federal healthcare beneficiaries and related to its relationships with third-party marketing agents. On this news, the Company's share price declined by $9.75 per share, or approximately 20.8%, from $46.89 per share to close at $37.14 per share on November 9, 2021.

If you purchased or otherwise acquired Oak Street securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP by email at [e-mail], or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: http://www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.